News by Tag: Global Biosimilars Market
Government Regulations Propelling Biosimilars in US
December 12, 2012
In recent times, US is taking a renowned interest in the biosimilars' industry by clearly structuring its industry's regulatory guidelines", says RNCOS in its latest research report.
December 12, 2012
In recent times, US is taking a renowned interest in the biosimilars' industry by clearly structuring its industry's regulatory guidelines", says RNCOS in its latest research report.
Global Biosimilars Market Forecast to 2015
September 4, 2012
RNCOS has recently added a new Market Research Report titled, "Global Biosimilars Market Forecast to 2015" to its report gallery. The report provides extensive research on the Global biosimilars market.
September 4, 2012
RNCOS has recently added a new Market Research Report titled, "Global Biosimilars Market Forecast to 2015" to its report gallery. The report provides extensive research on the Global biosimilars market.
Cancer Top Therapeutic Area in Biosimilars Development
April 2, 2012
Among major therapeutic segments, cancer-related biosimilars will be the market leader, says RNCOS' latest research report.
April 2, 2012
Among major therapeutic segments, cancer-related biosimilars will be the market leader, says RNCOS' latest research report.
Pipeline Biosimilar mAbs to Grow Stupendously in the Biosimilars Industry
March 28, 2012
Monoclonal Antibodies account for the fastest growing segment in the pipeline products of the Global Biosimilars Industry, says RNCOS.
March 28, 2012
Monoclonal Antibodies account for the fastest growing segment in the pipeline products of the Global Biosimilars Industry, says RNCOS.
Patent Expiration of Blockbuster Biologics Leading Splendid Growth of Global Biosimilars
March 19, 2012
Globally, biosimilars are anticipated to witness US$ 2.5 Billion growth by 2015-end, growing at a double-digit rate, says RNCOS.
March 19, 2012
Globally, biosimilars are anticipated to witness US$ 2.5 Billion growth by 2015-end, growing at a double-digit rate, says RNCOS.
Indian Biosimilars Industry Poised for Immense Growth
July 26, 2011
With more than 130 companies in the biopharmaceutical market, the Indian biosimilars industry is all set for incessant growth in the coming years, says RNCOS.
July 26, 2011
With more than 130 companies in the biopharmaceutical market, the Indian biosimilars industry is all set for incessant growth in the coming years, says RNCOS.
Pharma-Biotech Allies Driving the Global Biosimilars Industry
July 7, 2011
Many large pharma and biotech companies have joined hands and are looking forward to launch biosimilars program, says RNCOS in its latest research study.
July 7, 2011
Many large pharma and biotech companies have joined hands and are looking forward to launch biosimilars program, says RNCOS in its latest research study.